Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05989828
Title A2-ESO-1 TCR-Engineered T Cells for Relapsed/Refractory Advanced or Metastatic NY-ESO-1 Overexpression Positive Triple Negative Breast Cancer
Recruitment Not yet recruiting
Gender female
Phase Phase I
Variant Requirements No
Sponsors University of Southern California
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.